| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/06/2010 | US7749967 immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100; peptide being reactive with T cells or inducing an immune response; anticarcinogenic agents |
| 07/06/2010 | US7749964 treating osteoarthritis with OSTEOCHONDRAL GRAFTS consisting of ACTIVE GROWTH FACTORBONE MORPHOGENETIC PROTEIN |
| 07/06/2010 | US7749963 Isolated recombinant vaccinia virus complement control protein (hrVCP) polypeptide |
| 07/06/2010 | US7749962 administering to mammal with breast cancer as adjuvant therapy an agent effective in blocking interaction of integrin with extracellular matrix protein of bone marrow microenvironment or that downregulates expression of integrin; integrin is alpha 5 beta 1 and extracellular matrix protein is fibronectin |
| 07/06/2010 | US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function |
| 07/06/2010 | US7749959 Use of HMGB fragments as anti-inflammatory agents |
| 07/06/2010 | US7749958 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents |
| 07/06/2010 | US7749955 separating two forms of a polypeptide having a single amino acid racemization by eluting the two forms of the polypeptide from an ion exchange chromatography resin under conditions where the salt concentration is increased at a pH that is no more than 1 pH unit from a pKa of X |
| 07/06/2010 | US7749953 comprising regulating the expression or activity of cannabinoid receptors in bone cells |
| 07/06/2010 | US7749760 Nutrient broth comprising zoledronate, interleukin 2, and interleukin 18 for use in propagation of tumor specific lymphocytes; antitumor agents; tissue targeted therapy; immunotherapy |
| 07/06/2010 | US7749759 Cell compositions useful for cell-based FRET assays for clostridial toxins |
| 07/06/2010 | US7749758 Human and mammalian stem cell-derived neuron survival factors |
| 07/06/2010 | US7749756 Transgenic escherichia for use as bioreactor for fermentation of hydrolase, outermembrane, periplasmic binding, transport and/or flagellin protein |
| 07/06/2010 | US7749755 Nucleic acid for modulating apoptosis |
| 07/06/2010 | US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies |
| 07/06/2010 | US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 07/06/2010 | US7749746 Nucleic acid encoding 238P1B2 useful in detecting cancer |
| 07/06/2010 | US7749744 Hybrid enzymes |
| 07/06/2010 | US7749738 Using transgenic escherichia as bioreactor for alanine production for use in processed food industry, animal feeds and human parenteral nutrition supplements |
| 07/06/2010 | US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/06/2010 | US7749733 Expression vector for identifying promoter region of genes; gene expression modulators |
| 07/06/2010 | US7749731 Using acid lysis to release translation products from cells |
| 07/06/2010 | US7749721 Immuno enzymatic quantification method for cholesterol ester transferring protein (CETP) |
| 07/06/2010 | US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy |
| 07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
| 07/06/2010 | US7749715 TCL-1 gene and protein and related methods and compositions |
| 07/06/2010 | US7749710 Marker for stem cells and its use |
| 07/06/2010 | US7749699 Detection of chemical ligation using fluorescence quenching leaving groups |
| 07/06/2010 | US7749695 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
| 07/06/2010 | US7749518 Viral protein for use in devloping vaccine for treatment and preventon of infection, vision, arthritic and respiratory system disorders |
| 07/06/2010 | US7749516 Immunization of dairy cattle with GapC protein against Streptococcus infection |
| 07/06/2010 | US7749514 Activatable clostridial toxins |
| 07/06/2010 | US7749507 Malaria vaccine |
| 07/06/2010 | US7749506 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans |
| 07/06/2010 | US7749505 Immunogenic polypeptides for use in targeted treatment and prevention of cell proliferative disorders associated with respiratory system |
| 07/06/2010 | US7749502 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 07/06/2010 | US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof |
| 07/06/2010 | US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 07/06/2010 | US7749496 Neuronal regeneration |
| 07/06/2010 | US7749493 Chimeric adenoviruses |
| 07/06/2010 | US7749492 Adeno-associated virus vectors with modified capsid proteins for use as gene transfer and proliferation tools; gene therapy; genetic vaccines |
| 07/06/2010 | US7749490 Modified interleukin 10 polypeptide for use in treatment and prevention of neuropathic pain, neurological and inflammatory disorders |
| 07/06/2010 | CA2522067C Detection, characterization and treatment of viral infection and methods thereof |
| 07/06/2010 | CA2461199C Atlastin |
| 07/06/2010 | CA2328056C Attenuated mutants of salmonella which constitutively express the vi antigen |
| 07/06/2010 | CA2298864C Chemical modification of proteins to improve biocompatibility and bioactivity |
| 07/06/2010 | CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/06/2010 | CA2162729C Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
| 07/06/2010 | CA2150785C Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 07/06/2010 | CA2123049C Pharmaceutical containing the p40 subunit of interleukin 12 |
| 07/01/2010 | WO2010075575A1 Compositions and methods for re-programming cells without genetic modification |
| 07/01/2010 | WO2010075548A2 Immunoglobulin variants with altered binding to protein a |
| 07/01/2010 | WO2010075498A2 Axmi-150 delta-endotoxin gene and methods for its use |
| 07/01/2010 | WO2010075460A1 Alkylated interleukin-18 and related compositions, kits, and methods of making and using same |
| 07/01/2010 | WO2010075417A1 Survivin specific t cell receptor for treating cancer |
| 07/01/2010 | WO2010075375A1 Compositions, methods and related uses for cleaving modified dna |
| 07/01/2010 | WO2010075352A1 Pesticidal genes from brevibacillus and methods for their use |
| 07/01/2010 | WO2010075303A1 Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same |
| 07/01/2010 | WO2010075243A2 Nucleotide sequences encoding gsh1 polypeptides and methods of use |
| 07/01/2010 | WO2010075238A1 Human cgrp receptor binding proteins |
| 07/01/2010 | WO2010075159A1 Purification of recombinantly produced interferon |
| 07/01/2010 | WO2010074972A1 Polypeptides having catalase activity and polynucleotides encoding same |
| 07/01/2010 | WO2010074794A2 Membrane transduction peptides, polynucleotides, and methods |
| 07/01/2010 | WO2010074575A2 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. |
| 07/01/2010 | WO2010074552A1 Collagen extraction from aquatic animals |
| 07/01/2010 | WO2010074082A1 Modified vasohibin |
| 07/01/2010 | WO2010074081A1 Protein substance having triple helix structure and manufacturing method therefor |
| 07/01/2010 | WO2010073551A1 C1orf59 peptides and vaccines including the same |
| 07/01/2010 | WO2010073019A1 Ljungan virus |
| 07/01/2010 | WO2010073009A2 Compounds, compositions and use |
| 07/01/2010 | WO2010072900A1 Oncolytic adenoviral vectors and methods and uses related thereto |
| 07/01/2010 | WO2010072804A1 Hnrnp a3 related peptides and use thereof for diagnosis of rheumatoid arthritis |
| 07/01/2010 | WO2010072621A2 Process for the preparation of a peptide powder form |
| 07/01/2010 | WO2010072418A1 A process for purifying a polymer mixture |
| 07/01/2010 | WO2010072406A1 Novel transporter constructs and transporter cargo conjugate molecules |
| 07/01/2010 | WO2010072405A1 Efficient transport into white blood cells |
| 07/01/2010 | WO2010072275A1 Efficient delivery of medicaments into white blood cells |
| 07/01/2010 | WO2010072228A1 Novel transporter constructs and transporter cargo conjugate molecules |
| 07/01/2010 | WO2010071995A1 Tor-interacting proteins (tips) and genes therefor |
| 07/01/2010 | WO2010071986A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides |
| 07/01/2010 | WO2010071983A1 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators |
| 07/01/2010 | WO2010071938A1 Novel collagen constructs |
| 07/01/2010 | WO2010054156A3 Vaccines targeting cellular death receptors |
| 07/01/2010 | WO2010053990A3 Crhr2 peptide agonists and uses thereof |
| 07/01/2010 | WO2010037864A3 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 07/01/2010 | WO2010030653A3 Nurr1 interacting protein (nuip) |
| 07/01/2010 | WO2010027818A3 Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use |
| 07/01/2010 | WO2010027473A3 Immunogenic escherichia coli heat stable enterotoxin |
| 07/01/2010 | WO2010024704A4 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 07/01/2010 | WO2010022260A3 Novel toxin-antitoxin system |
| 07/01/2010 | WO2010002478A3 Glycopeptide and uses thereof |
| 07/01/2010 | US20100170007 Genes controlling winter dormancy in perennials and uses thereof |
| 07/01/2010 | US20100170003 Transgenic Plants with Increased Stress Tolerance and Yield |
| 07/01/2010 | US20100169988 Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
| 07/01/2010 | US20100168403 Protein refolding agent and refolding method |
| 07/01/2010 | US20100168402 Direct Attachment of Polypeptides to Virus Like Particles |
| 07/01/2010 | US20100168401 Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes |
| 07/01/2010 | US20100168399 Antibodies that bind b7l-1 |
| 07/01/2010 | US20100168398 Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom. |
| 07/01/2010 | US20100168397 Therapeutic use of anti-cs1 antibodies |